Dec 02, 2020
744:667
For every 667 shares held, investors received 744. The price per share adjusted from $22.90 to $20.53.
The split itself did not change the total investment value.
NextCell Pharma AB (STO:NXTCL) operates in the Pharmaceuticals: major industry.
NextCell Pharma AB company overviewNextCell Pharma AB's most recent stock split was on December 2, 2020. It was a 744-for-667 forward split, so shareholders received 744 shares for every 667 they held.
NextCell Pharma AB has split its stock once. This history records one forward split, on December 2, 2020.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In NextCell Pharma AB's 744-for-667 split on December 2, 2020, every 667 shares became 744 shares.
NextCell Pharma AB has not announced a new split in our records. Its most recent split was on December 2, 2020, 5 years ago. Companies announce splits in advance, and any new STO:NXTCL split will appear on this page.
Already premium?